US Patent 4,508,905 scope, claim structure, and US patent landscape for the covered compound class
US Patent 4,508,905 (United States) has claim coverage directed to a substituted compound class defined by a core structural formula with specific position-dependent substituent variables (R1-R6) and a set of enumerated substituents. As written, the claims are broad at the “formula” level (multiple independently selected substituents) but narrow at enforcement-to-practice because (1) coverage depends on matching the exact scaffold in the issued claim formula and (2) each substituent position is limited to a finite list.
Because the request provides only the text of claims 1-3 (and not the claim-1 chemical structure in full fidelity), this analysis is limited to the scope that can be derived from the enumerated variables and claim dependencies you supplied. No external Orange Book, litigation, assignment, or related-family dataset is included here because those records are not in the provided material.
What does claim 1 cover in plain structure terms?
Claim 1 covers “a compound of the formula” with:
- R1 and R2 independently selected from:
- hydrogen
- alkyl C1–C7
- halogen
- carbomethoxy (–COOCH3)
- carboethoxy (–COOCH2CH3)
- alkoxy up to C5 (–OR, R = 1–5 carbons)
- alkanoyl up to C4 (acyl, –COR with acyl chain C1–C4)
- R6 selected from: hydrogen, methyl, ethyl
- R3 and R5 independently selected from: hydrogen, methyl, methoxy, ethoxy, methoxyethoxy, ethoxyethoxy
- R4 selected from: methoxy, ethoxy, methoxyethoxy, ethoxyethoxy
Enforcement implication: A product candidate or intermediate must match:
- the exact ring/connecting scaffold shown by the claim’s “formula” (the structure itself is not reproduced in the prompt), and
- the substituent options at each labeled position (R1-R6), including the constraint that R4 cannot be hydrogen and is limited to four ether-type substituents.
What is claim 2 doing?
Claim 2 is a narrower species claim that pins down a single substitution pattern:
- R1 = methoxy
- R2 = hydrogen
- R3 = methyl
- R4 = methoxy
- R5 = methyl
- R6 = hydrogen
So claim 2 is enforceable only for compounds matching that complete pattern.
What is claim 3 doing?
Claim 3 is also a species-definition claim, but instead of a single example it lists a table of allowed combinations (R1, R2, R6, R3, R4, R5) and mapped substituents at each variable position.
From the table you provided, claim 3 covers the following explicit substitution sets (each row is one covered compound):
- R1 5-COCH3; R2 6-CH3; R6 H; R3 H; R4 OCH3; R5 H
- R1 4-CH3; R2 6-CH3; R6 H; R3 H; R4 OCH3; R5 H
- R1 5-COCH3; R2 6-CH3; R6 H; R3 CH3; R4 OCH3; R5 CH3
- R1 5-COOCH3; R2 6-CH3; R6 H; R3 H; R4 OCH3; R5 H
- R1 5-COOCH3; R2 6-CH3; R6 H; R3 H; R4 OC2H5; R5 H
- R1 5-COOCH3; R2 6-CH3; R6 H; R3 CH3; R4 OCH3; R5 H
- R1 5-COOCH3; R2 6-CH3; R6 H; R3 CH3; R4 OCH3; R5 CH3
- R1 5-COOCH3; R2 6-CH3; R6 H; R3 H; R4 OCH3; R5 CH3
- R1 5-COCH3; R2 H; R6 H; R3 H; R4 CH3OCH3; R5 CH3
- R1 5-OCH3; R2 H; R6 H; R3 H; R4 OCH3; R5 CH3
- R1 5-OCH3; R2 H; R6 H; R3 CH3; R4 OCH3; R5 CH3
- R1 5-CH3; R2 H; R6 H; R3 CH3; R4 OCH3; R5 CH3
- R1 5-Cl; R2 H; R6 H; R3 CH3; R4 OCH3; R5 CH3
- R1 5-CH3; R2 H; R6 H; R3 H; R4 O(C2H4)OCH3; R5 H (as shown “OC2H4OCH3”)
- R1 5-COOC2H5; R2 H; R6 H; R3 CH3; R4 OCH3; R5 CH3 (as shown “5-COOC2H5 … CH3 OCH3 CH3”)
Enforcement implication: A non-covered compound that differs at any listed R-position from these exact patterns does not fall in claim 3, but may still fall in claim 1 if the substitution remains within the enumerated lists.
How broad is the claim 1 “formula” coverage versus the species claims 2 and 3?
Claim 1: combinatorial breadth with hard cutoffs
The scope is driven by independent choices at each variable:
- R4 is most restrictive (only four ether substituents; no H).
- R6 is limited to H/methyl/ethyl.
- R3 and R5 are limited to H/methyl/three ether-classes.
- R1 and R2 have the widest menu, including acyl and ester-type substituents plus alkyl/alkoxy/halogen.
Because each position is capped to specific options, claim 1 is not “open-ended” in substituent size or functionality, even though it is broad across positions.
Claim 2 and 3: narrower, higher evidentiary certainty
Species claims reduce interpretive ambiguity. In licensing or litigation, claim 1 disputes often turn on:
- whether a candidate structure matches the scaffold exactly, and
- whether a given substituent is properly mapped to the R-labeled positions.
Species claims (2 and 3) reduce these issues because the full set of substituents is fixed.
What does the R-position substitution set imply for freedom-to-operate design?
R4 as a key design constraint
Claim 1 requires:
- R4 ∈ {methoxy, ethoxy, methoxyethoxy, ethoxyethoxy}
So a design that makes R4 a different substituent type (example: hydrogen, halogen, carbonyl, nitrile, hydroxy directly, or larger alkoxy beyond the listed ether classes) would not satisfy claim 1’s R4 constraint.
R6 as a key “small substituent” constraint
Claim 1 requires:
Thus, substitutions like propyl, tert-butyl, fluoromethyl, trifluoromethyl, or other groups would fall outside the R6 list.
R3 and R5: ether-type allowance limited to the “ethoxyethoxy/methoxyethoxy” classes
R3 and R5 allow:
- H, methyl, methoxy, ethoxy, methoxyethoxy, ethoxyethoxy
So the “ether tail” must match those specific connectivity options, not just any polyether.
R1 and R2: broad but still enumerated
R1 and R2 allow:
- alkyl C1–C7
- halogen
- alkoxy C1–C5
- alkanoyl C1–C4
- methoxycarbonyl (carbomethoxy), ethoxycarbonyl (carboethoxy)
- hydrogen
Substituent types outside these lists are excluded, including:
- sulfonamides, sulfonates, phosphonates
- cyano
- nitro
- amino
- carboxylic acid (not listed as such; only ester-carbonyl forms listed as carbomethoxy/carboethoxy in your prompt)
- larger alkoxy beyond C5
What patents protect the same compound class besides US 4,508,905?
No additional patents are identified in the prompt. The provided material contains only claim text for US 4,508,905 and does not include:
- patent family members
- priority application numbers
- assignee names
- related continuation/divisional publications
- citations of other patents
- any litigation or licensing history
So a reliable landscape cannot be produced from the information provided.
What litigation, settlements, Paragraph IV, Orange Book status, or generic risk can be inferred?
None of the following are present in the prompt:
- FDA NDA/ANDA linkage
- Orange Book listing
- listed patents by NDA holder
- any certification or Hatch-Waxman docket events
- any Paragraph IV or settlement date
- any biosimilar or generic launch timelines
- any competing products
So it is not possible to map US 4,508,905 to exclusivity and entry risk using only the provided claim text.
Patent strength: how to score enforceability based on claim structure only?
Strength factors
- The claims are structural with explicit enumerated substituent lists.
- Claim 2 and claim 3 are species-defining patterns, narrowing claim interpretation.
- R4 and R6 constraints are “hard” and reduce reach.
Vulnerability factors
- Claim 1 depends on the exact scaffold in the “formula” shown in the patent. Without the full structure rendering, infringement analysis hinges on whether a candidate structure matches the precise backbone and position numbering.
- If later prosecution history or claim construction narrows interpretation of the formula variables, claim 1 may contract in practice. (No prosecution history is included in the prompt.)
Practical infringement check matrix for compounds near the edge of the enumerated lists
The following matrix is designed to evaluate whether a candidate compound is inside or outside based on substituent categories stated in your claim text.
| Candidate feature |
If it matches claim list |
Result for claim 1 (subject to scaffold match) |
| R4 = methoxy/ethoxy/methoxyethoxy/ethoxyethoxy |
Yes |
Potentially in scope |
| R4 = hydrogen or non-listed group |
No |
Out of scope |
| R6 = H/methyl/ethyl |
Yes |
Potentially in scope |
| R6 = other substituent (propyl, CF3, aryl, etc.) |
No |
Out of scope |
| R3/R5 ∈ {H, methyl, methoxy, ethoxy, methoxyethoxy, ethoxyethoxy} |
Yes |
Potentially in scope |
| R3/R5 = other ether/polyether type not in list |
No |
Out of scope |
| R1/R2 ∈ enumerated: H, alkyl C1–C7, halogen, carbomethoxy/carboethoxy, alkoxy C≤5, alkanoyl C≤4 |
Yes |
Potentially in scope |
| R1/R2 has substituent type outside enumerated list (e.g., sulfonamide, cyano, nitro, acid) |
No |
Out of scope |
| Overall scaffold differs from claim formula |
N/A |
Out of scope |
Key takeaways
- US Patent 4,508,905 claim 1 covers a substituted compound class defined by a formula with enumerated substituent variables R1-R6. The broadest reach is for R1 and R2; the tightest constraint is R4 (no hydrogen; only methoxy/ethoxy/methoxyethoxy/ethoxyethoxy).
- Claim 2 is a single fixed substitution pattern (R1 methoxy; R2 H; R3 methyl; R4 methoxy; R5 methyl; R6 H).
- Claim 3 covers a finite set of specific substitution combinations listed in the table you provided; these are enforceable only for those patterns.
- No patent family, litigation, Orange Book status, Paragraph IV activity, or FDA linkage can be derived from the provided content.
FAQs
1) Does changing only R4 eliminate coverage under US 4,508,905?
Yes, because claim 1 limits R4 to methoxy, ethoxy, methoxyethoxy, or ethoxyethoxy. Any other substituent at the R4 position is outside claim 1.
2) Are R3 and R5 required to be the same substituent in claim 1?
No. Claim 1 allows R3 and R5 to be independently selected from the same enumerated list.
3) Can R1 and R2 both be halogens under claim 1?
Yes, since each of R1 and R2 can independently be hydrogen or halogen (or other listed substituents).
4) Is a compound with R6 = propyl covered by claim 1?
No. Claim 1 restricts R6 to hydrogen, methyl, or ethyl.
5) If a compound is not one of the listed rows in claim 3, can it still fall under claim 1?
Yes. Claim 3 is a narrower species list; claim 1 can still cover compounds that match the scaffold and fall within the enumerated R-position options.
References
- US Patent 4,508,905. Claims 1-3 (as provided in prompt).
